Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Büttner HJ, Neumann FJ.

J Am Coll Cardiol. 2006 Nov 7;48(9):1742-50. Epub 2006 Oct 17.

2.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
3.

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL.

Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Review.

PMID:
20826265
4.

Optimizing platelet P2Y12 inhibition for patients undergoing PCI.

Steinhubl S, Roe MT.

Cardiovasc Drug Rev. 2007 Summer;25(2):188-203. Review. Erratum in: Cardiovasc Drug Rev. 2007 Autumn;25(3):299.

PMID:
17614940
5.

Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV.

Am Heart J. 2007 Aug;154(2):221-31. Review.

PMID:
17643570
6.

Clopidogrel in interventional cardiology: questions answered and questions remaining.

Nikhil JY, Radhakrishnan S, Paradiso-Hardy FL, Cohen EA.

Can J Cardiol. 2002 Jul;18(7):739-48. Review.

PMID:
12167961
7.

Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.

Vlaar PJ, Svilaas T, Damman K, de Smet BJ, Tijssen JG, Hillege HL, Zijlstra F.

Circulation. 2008 Oct 28;118(18):1828-36. doi: 10.1161/CIRCULATIONAHA.107.749531. Epub 2008 Oct 13. Review.

8.

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.

Lotrionte M, Biondi-Zoccai GG, Agostoni P, Abbate A, Angiolillo DJ, Valgimigli M, Moretti C, Meliga E, Cuisset T, Alessi MC, Montalescot G, Collet JP, Di Sciascio G, Waksman R, Testa L, Sangiorgi G, Laudito A, Trevi GP, Sheiban I.

Am J Cardiol. 2007 Oct 15;100(8):1199-206. Epub 2007 Jul 30. Review.

PMID:
17920357
9.

Clopidogrel: potential in the prevention of cardiovascular events in patients with acute coronary syndromes.

Easthope SE, Jarvis B.

Am J Cardiovasc Drugs. 2001;1(6):467-74; discussion 475-6. Review.

PMID:
14728005
10.

[Dual antithrombotic therapy after implantation of coronary stents].

Schneider H, Weber F, Holzhausen C, Körber T, Ince H, Rehders T, Nienaber CA.

Dtsch Med Wochenschr. 2006 May 12;131(19):1105-10. Review. German.

PMID:
16685632
11.

Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.

Hamdalla H, Moliterno DJ.

Expert Opin Pharmacother. 2006 Aug;7(12):1669-73. Review.

PMID:
16872270
12.

Clopidogrel in acute coronary heart disease.

Din JN, Fox KA.

Am Heart Hosp J. 2005 Fall;3(4):234-42. Review.

PMID:
16330915
13.
14.

High-dose clopidogrel loading in percutaneous coronary intervention.

Longstreth KL, Wertz JR.

Ann Pharmacother. 2005 May;39(5):918-22. Epub 2005 Apr 5. Review.

PMID:
15811910
15.

[Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].

Baralis G, Steffenino G, Dellavalle A, La Scala E, Uslenghi E.

Ital Heart J Suppl. 2003 Sep;4(9):766-70. Review. Italian.

PMID:
14635395
16.

Clopidogrel use in coronary artery disease.

Baggish AL, Sabatine MS.

Expert Rev Cardiovasc Ther. 2006 Jan;4(1):7-15. Review.

PMID:
16375623
17.

Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.

Vila PM, Zafar MU, Badimon JJ.

Platelets. 2009 Dec;20(8):531-8. doi: 10.3109/09537100903261379. Review.

PMID:
19845440
18.

Clopidogrel resistance: implications for coronary stenting.

Gurbel PA, Lau WC, Bliden KP, Tantry US.

Curr Pharm Des. 2006;12(10):1261-9. Review.

PMID:
16611110
19.

Drug insight: Clopidogrel nonresponsiveness.

Gurbel PA, Tantry US.

Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95. Review.

PMID:
16810174
20.

Platelet ADP receptor antagonists: ticlopidine and clopidogrel.

Jacobson AK.

Best Pract Res Clin Haematol. 2004 Mar;17(1):55-64. Review.

PMID:
15171957
Items per page

Supplemental Content

Write to the Help Desk